Cosyne Therapeutics Limited LONDON


Cosyne Therapeutics Limited is a private limited company situated at 2 Sheraton Street, Wework Medius House, London W1F 8BH. Incorporated on 2021-02-01, this 3-year-old company is run by 2 directors.
Director Louwai M., appointed on 01 February 2021. Director Liisi L., appointed on 01 February 2021.
The company is officially classified as "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110).
The latest confirmation statement was sent on 2023-01-31 and the due date for the subsequent filing is 2024-02-14. What is more, the accounts were filed on 28 February 2023 and the next filing should be sent on 30 November 2024.

Cosyne Therapeutics Limited Address / Contact

Office Address 2 Sheraton Street
Office Address2 Wework Medius House
Town London
Post code W1F 8BH
Country of origin United Kingdom

Company Information / Profile

Registration Number 13171951
Date of Incorporation Mon, 1st Feb 2021
Industry Research and experimental development on biotechnology
End of financial Year 28th February
Company age 3 years old
Account next due date Sat, 30th Nov 2024 (209 days left)
Account last made up date Tue, 28th Feb 2023
Next confirmation statement due date Wed, 14th Feb 2024 (2024-02-14)
Last confirmation statement dated Tue, 31st Jan 2023

Company staff

Louwai M.

Position: Director

Appointed: 01 February 2021

Liisi L.

Position: Director

Appointed: 01 February 2021

Michael J.

Position: Director

Appointed: 01 February 2021

Resigned: 19 May 2023

People with significant control

The list of PSCs who own or control the company consists of 3 names. As we discovered, there is Liisi L. This PSC has 25-50% voting rights and has 25-50% shares. The second one in the persons with significant control register is Michael J. This PSC owns 25-50% shares and has 25-50% voting rights. Moving on, there is Louwai M., who also fulfils the Companies House conditions to be listed as a person with significant control. This PSC owns 25-50% shares and has 25-50% voting rights.

Liisi L.

Notified on 1 February 2021
Ceased on 16 May 2022
Nature of control: 25-50% voting rights
right to appoint and remove directors
25-50% shares

Michael J.

Notified on 1 February 2021
Ceased on 16 May 2022
Nature of control: 25-50% voting rights
right to appoint and remove directors
25-50% shares

Louwai M.

Notified on 1 February 2021
Ceased on 16 May 2022
Nature of control: 25-50% voting rights
right to appoint and remove directors
25-50% shares

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Resolutions: Resolution
filed on: 1st, September 2023
Free Download (5 pages)

Company search